OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Molnupiravir for the Treatment of Mild or Moderate COVID-19 in Adults: A Meta-Analysis
Karima Benaicha, Raja Ram Khenhrani, Maha Veer, et al.
Cureus (2023)
Open Access | Times Cited: 13

Showing 13 citing articles:

From Emergence to Endemicity: A Comprehensive Review of COVID-19
Roopa Naik, Sreekant Avula, Sujith K Palleti, et al.
Cureus (2023)
Open Access | Times Cited: 11

Orally Bioavailable RORγ/DHODH Dual Host-Targeting Small Molecules with Broad-Spectrum Antiviral Activity
Alexandra Herrmann, Christian Gege, Christina Wangen, et al.
Antiviral Research (2024), pp. 106008-106008
Open Access | Times Cited: 3

Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses—a systematic review
Emma J Ragel, Lynda K. Harris, Richard A. Campbell
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001525-e001525
Open Access | Times Cited: 8

Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis
Bahman Amani, Behnam Amani
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0298772-e0298772
Open Access | Times Cited: 2

In vitro testing of host-targeting small molecule antiviral matriptase/TMPRSS2 inhibitors in 2D and 3D cell-based assays
Nicholas van Eijk, Luna C. Schmacke, Torsten Steinmetzer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115761-115761
Open Access | Times Cited: 5

Unveiling the future of COVID-19 patient care: groundbreaking prediction models for severe outcomes or mortality in hospitalized cases
Nguyen Thi Hien, Feng‐Jen Tsai, Y. W. Chang, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 1

Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors
Shengying Lin, Xiaoyang Wang, Roy Wai-Lun Tang, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2636-2636
Open Access | Times Cited: 1

Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis
Bahman Amani, Behnam Amani
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1

Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
Giuseppe A. Ramirez, Maria Gerosa, Chiara Bellocchi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1273-1273
Open Access | Times Cited: 3

COVID-19: From Emergence to Endemicity - A Comprehensive Review
Roopa Naik, Sreekant Avula, Sujith K Palleti, et al.
(2023)
Open Access | Times Cited: 2

Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial
Imam Adi Wicaksono, Cecep Suhandi, Khaled M. Elamin, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22839-e22839
Open Access | Times Cited: 2

The COVID-19 Pandemic and Its Impact on Patient Safety Incidents at a University Hospital: A Retrospective Study
Rie Koyoshi, Shin-ichiro Miura, Satoshi Imaizumi, et al.
Clinical Infection and Immunity (2024) Vol. 9, Iss. 1, pp. 1-10
Open Access

Covid-19 A Comprehensive Review of Signs, Symptoms, Diagnosis, and Treatment Strategies
Mr. Kachare Vishal, Prof. Waghmare S. U., Poonam B. Kodage
International Journal of Advanced Research in Science Communication and Technology (2024), pp. 51-68
Open Access

Page 1

Scroll to top